{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:14:35Z","timestamp":1789593275999,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Terlipressin, a long-acting synthetic analogue of vasopressin has been used in the adult population for various indications including hepatorenal syndrome (HRS-AKI), esophageal variceal hemorrhage (EVH) and shock, but its use in pediatrics is still limited to individualized cases and data on safety and efficacy is scant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We reviewed the patient records of children with liver disease and Acute Kidney Injury requiring terlipressin admitted to the Paediatric Intensive Care Unit (PICU) of King\u2019s College Hospital, London from January 2010\u2013December 2017, with special emphasis on its effect on renal parameters and adverse event profile.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-one terlipressin administration records in a total of 16 patients (median) (IQR) 10\u2009years (6.1\u201314.4) were included. The drug was initially given as a bolus dose in all cases, followed by either bolus or infusion with median dosage being 5.2 (3.8\u20136.7) mcg\/kg\/hour. After administration, a sustained increase of mean arterial pressure was observed. There was an improvement in serum creatinine (Cr) (at 24\u2009h; <jats:italic>p<\/jats:italic>\u2009=\u20090.386) and increase in urine output (UO), especially in the hepatorenal syndrome subgroup (HRS-AKI). We found minimal evidence of gastrointestinal side effects including feeding intolerance and vasoconstrictive side effects including cyanosis \/ ischaemia of extremities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Terlipressin was found to be safe in critically sick children with liver disease with positive impact on renal parameters which might be taken as a surrogate marker of HRS reversal, though effects on outcomes are difficult to ascertain. It is important to be aware of all its side-effects and actively watch for them. Future prospective studies are warranted to validate these findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-020-01914-6","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T13:04:32Z","timestamp":1597928672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Use of terlipressin in critically ill children with liver disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Romit","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Deep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"issue":"10","key":"1914_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1365-2044.2004.03877.x","volume":"59","author":"PCA Kam","year":"2004","unstructured":"Kam PCA, Williams S, Yoong FFY. Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia. 2004;59(10):993\u20131001.","journal-title":"Anaesthesia."},{"issue":"6","key":"1914_CR2","first-page":"307","volume":"16","author":"G Nilsson","year":"1990","unstructured":"Nilsson G, Lindblom P, Ohlin M, Berling R, Vernersson E. Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Drugs Exp Clin Res. 1990;16(6):307\u201314.","journal-title":"Drugs Exp Clin Res"},{"issue":"18","key":"1914_CR3","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","volume":"107","author":"MW D\u00fcnser","year":"2003","unstructured":"D\u00fcnser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107(18):2313\u20139.","journal-title":"Circulation."},{"issue":"9313","key":"1914_CR4","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S0140-6736(02)08225-9","volume":"359","author":"A O\u2019Brien","year":"2002","unstructured":"O\u2019Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet Lond Engl. 2002;359(9313):1209\u201310.","journal-title":"Lancet Lond Engl"},{"issue":"8","key":"1914_CR5","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/00003246-199708000-00012","volume":"25","author":"DW Landry","year":"1997","unstructured":"Landry DW, Levin HR, Gallant EM, Seo S, D\u2019Alessandro D, Oz MC, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med. 1997;25(8):1279\u201382.","journal-title":"Crit Care Med"},{"issue":"4","key":"1914_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","volume":"47","author":"MB Malay","year":"1999","unstructured":"Malay MB, Ashton RC, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999;47(4):699\u2013703 discussion 703-705.","journal-title":"J Trauma"},{"issue":"1","key":"1914_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2036.2003.01356.x","volume":"17","author":"GN Ioannou","year":"2003","unstructured":"Ioannou GN, Doust J, Rockey DC. Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther. 2003;17(1):53\u201364.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4 Pt 1","key":"1914_CR8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R Ortega","year":"2002","unstructured":"Ortega R, Gin\u00e8s P, Uriz J, C\u00e1rdenas A, Calahorra B, De Las HD, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatol Baltim Md. 2002;36(4 Pt 1):941\u20138.","journal-title":"Hepatol Baltim Md"},{"key":"1914_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJM196201182660307","volume":"266","author":"TC Merigan","year":"1962","unstructured":"Merigan TC, Plotkin GR, Davidson CS. Effect of intravenously administered posterior pituitary extract on hemorrhage from bleeding esophageal varices. A controlled evaluation. N Engl J Med. 1962;266:134\u20135.","journal-title":"N Engl J Med"},{"issue":"6","key":"1914_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1365-2036.2006.03086.x","volume":"24","author":"F Fabrizi","year":"2006","unstructured":"Fabrizi F, Dixit V, Martin P. Meta-analysis: terlipressin therapy for the hepatorenal syndrome. Aliment Pharmacol Ther. 2006;24(6):935\u201344.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"1914_CR11","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1440-1746.2009.06132.x","volume":"25","author":"SV Sagi","year":"2010","unstructured":"Sagi SV, Mittal S, Kasturi KS, Sood GK. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2010;25(5):880\u20135.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1914_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40272-016-0199-8","volume":"19","author":"J Michel","year":"2017","unstructured":"Michel J, Hofbeck M, Spiller G, Renk H, Kumpf M, Neunhoeffer F. Safety and efficacy of Terlipressin in pediatric distributive shock: a retrospective analysis in 20 children. Paediatr Drugs. 2017;19(1):35\u201341.","journal-title":"Paediatr Drugs"},{"issue":"1","key":"1914_CR13","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/cc3984","volume":"10","author":"A Rodr\u00edguez-N\u00fa\u00f1ez","year":"2006","unstructured":"Rodr\u00edguez-N\u00fa\u00f1ez A, L\u00f3pez-Herce J, Gil-Ant\u00f3n J, Hern\u00e1ndez A, Rey C, RETSPED Working Group of the Spanish Society of Pediatric Intensive Care. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit Care Lond Engl. 2006;10(1):R20.","journal-title":"Crit Care Lond Engl"},{"issue":"1","key":"1914_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/MPG.0b013e3181d60e73","volume":"51","author":"N Yousef","year":"2010","unstructured":"Yousef N, Habes D, Ackermann O, Durand P, Bernard O, Jacquemin E. Hepatorenal syndrome: diagnosis and effect of terlipressin therapy in 4 pediatric patients. J Pediatr Gastroenterol Nutr. 2010;51(1):100\u20132.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"1914_CR15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","volume":"62","author":"A Paolo","year":"2015","unstructured":"Paolo A, Gin\u00e8s P, Wong F, Bernardi M, Boyer TD, Gerbes A, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62(4):968\u201374.","journal-title":"J Hepatol"},{"issue":"9","key":"1914_CR16","first-page":"1310","volume":"56","author":"F Salerno","year":"2007","unstructured":"Salerno F, Gerbes A, Gin\u00e8s P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56(9):1310\u20138.","journal-title":"Gut."},{"issue":"3","key":"1914_CR17","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/CCM.0b013e31819b8199","volume":"37","author":"F Ryckwaert","year":"2009","unstructured":"Ryckwaert F, Virsolvy A, Fort A, Murat B, Richard S, Guillon G, et al. Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performance. Crit Care Med. 2009;37(3):876\u201381.","journal-title":"Crit Care Med"},{"issue":"2","key":"1914_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","volume":"18","author":"P Solanki","year":"2003","unstructured":"Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol. 2003;18(2):152\u20136.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"1914_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jcrc.2013.02.016","volume":"28","author":"N Fayed","year":"2013","unstructured":"Fayed N, Refaat EK, Yassein TE, Alwaraqy M. Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation. J Crit Care. 2013;28(5):775\u201382.","journal-title":"J Crit Care"},{"issue":"4","key":"1914_CR20","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R Ortega","year":"2002","unstructured":"Ortega R, Gin\u00e8s P, Andr\u00e9s JU, C\u00e1rdenas A, Calahorra B. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002;36(4):941\u20138.","journal-title":"Hepatology."},{"issue":"Suppl 1","key":"1914_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1440-1746.2010.06583.x","volume":"26","author":"H Rajekar","year":"2011","unstructured":"Rajekar H, Chawla Y. Terlipressin in hepatorenal syndrome: evidence for present indications. J Gastroenterol Hepatol. 2011;26(Suppl 1):109\u201314.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"1914_CR22","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","volume":"134","author":"M Mart\u00edn-Llah\u00ed","year":"2008","unstructured":"Mart\u00edn-Llah\u00ed M, P\u00e9pin M-N, Guevara M, D\u00edaz F, Torre A, Monescillo A, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008;134(5):1352\u20139.","journal-title":"Gastroenterology."},{"issue":"4","key":"1914_CR23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1053\/gast.2002.32364","volume":"122","author":"R Moreau","year":"2002","unstructured":"Moreau R, Durand F, Poynard T, Duhamel C, Cervoni J-P, Icha\u00ef P, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology. 2002;122(4):923\u201330.","journal-title":"Gastroenterology."},{"issue":"8","key":"1914_CR24","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1097\/00003246-200208000-00038","volume":"30","author":"JM Kahn","year":"2002","unstructured":"Kahn JM, Kress JP, Hall JB. Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Crit Care Med. 2002;30(8):1899\u2013901.","journal-title":"Crit Care Med"},{"issue":"4","key":"1914_CR25","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1097\/00003246-200004000-00064","volume":"28","author":"RJ Gazmuri","year":"2000","unstructured":"Gazmuri RJ, Ayoub IM. Pressors for cardiopulmonary resuscitation: is there a new kid on the block? Crit Care Med. 2000;28(4):1236\u20138.","journal-title":"Crit Care Med"},{"issue":"1","key":"1914_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1055\/s-0038-1661457","volume":"55","author":"PJ Grant","year":"1986","unstructured":"Grant PJ, Tate GM, Davies JA, Williams NS, Prentice CR. Intra-operative activation of coagulation--a stimulus to thrombosis mediated by vasopressin? Thromb Haemost. 1986;55(1):104\u20137.","journal-title":"Thromb Haemost"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01914-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01914-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01914-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T23:36:49Z","timestamp":1629416209000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01914-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1914"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01914-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"26 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Since this was a retrospective audit of already collected data, ethical approval was not required from the ethics committee, however this project was registered as an audit with the Audit and Quality Improvement team at King\u2019s College Hospital, London (Audit number- CH055).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Nil","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"360"}}